Research ArticleBasic Science Investigation
Noninvasive Nuclear Imaging Enables the In Vivo Quantification of Striatal Dopamine Receptor Expression and Raclopride Affinity in Mice
Kristina Fischer, Vesna Sossi, Andreas Schmid, Martin Thunemann, Florian C. Maier, Martin S. Judenhofer, Julia G. Mannheim, Gerald Reischl and Bernd J. Pichler
Journal of Nuclear Medicine July 2011, 52 (7) 1133-1141; DOI: https://doi.org/10.2967/jnumed.110.086942
Kristina Fischer
Vesna Sossi
Andreas Schmid
Martin Thunemann
Florian C. Maier
Martin S. Judenhofer
Julia G. Mannheim
Gerald Reischl
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 7
July 1, 2011
Noninvasive Nuclear Imaging Enables the In Vivo Quantification of Striatal Dopamine Receptor Expression and Raclopride Affinity in Mice
Kristina Fischer, Vesna Sossi, Andreas Schmid, Martin Thunemann, Florian C. Maier, Martin S. Judenhofer, Julia G. Mannheim, Gerald Reischl, Bernd J. Pichler
Journal of Nuclear Medicine Jul 2011, 52 (7) 1133-1141; DOI: 10.2967/jnumed.110.086942
Noninvasive Nuclear Imaging Enables the In Vivo Quantification of Striatal Dopamine Receptor Expression and Raclopride Affinity in Mice
Kristina Fischer, Vesna Sossi, Andreas Schmid, Martin Thunemann, Florian C. Maier, Martin S. Judenhofer, Julia G. Mannheim, Gerald Reischl, Bernd J. Pichler
Journal of Nuclear Medicine Jul 2011, 52 (7) 1133-1141; DOI: 10.2967/jnumed.110.086942
Jump to section
Related Articles
Cited By...
- In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice
- In Vivo Measurement of the Affinity and Density of Metabotropic Glutamate Receptor Subtype 1 in Rat Brain Using 18F-FITM in Small-Animal PET
- In Vivo Dopamine Transporter Imaging in a Unilateral 6-Hydroxydopamine Rat Model of Parkinson Disease Using 11C-Methylphenidate PET